These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16095812)

  • 21. [Experimental studies on inhibition of malignant melanoma growth by gene transfer of adenovirus-mediated averse vascular endothelial growth factor165].
    Cui Z; Cen Y; Zhang J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 May; 20(5):499-503. PubMed ID: 16752833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
    Younes MN; Yazici YD; Kim S; Jasser SA; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3425-34. PubMed ID: 16740767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
    Thejass P; Kuttan G
    Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
    Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
    Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
    Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ
    Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative effect in vitro and antitumor activity in vivo of brefeldin A.
    Sausville EA; Duncan KL; Senderowicz A; Plowman J; Randazzo PA; Kahn R; Malspeis L; Grever MR
    Cancer J Sci Am; 1996; 2(1):52-8. PubMed ID: 9166499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YM-231146, a novel orally bioavailable inhibitor of vascular endothelial growth factor receptor-2, is effective against paclitaxel resistant tumors.
    Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M
    Biol Pharm Bull; 2005 Nov; 28(11):2096-101. PubMed ID: 16272696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation.
    Hada K; Suda A; Asoh K; Tsukuda T; Hasegawa M; Sato Y; Ogawa K; Kuramoto S; Aoki Y; Shimma N; Ishikawa T; Koyano H
    Bioorg Med Chem; 2012 Feb; 20(4):1442-60. PubMed ID: 22269278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity.
    Zhang X; Fang X; Gao Z; Chen W; Tao F; Cai P; Yuan H; Shu Y; Xu Q; Sun Y; Gu Y
    Anticancer Drugs; 2014 Feb; 25(2):204-11. PubMed ID: 24135499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor effect of avermectins.
    Drinyaev VA; Mosin VA; Kruglyak EB; Novik TS; Sterlina TS; Ermakova NV; Kublik LN; Levitman MKh; Shaposhnikova VV; Korystov YN
    Eur J Pharmacol; 2004 Oct; 501(1-3):19-23. PubMed ID: 15464058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
    Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
    PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals. Part 5.
    Takeda Y; Uoto K; Iwahana M; Jimbo T; Nagata M; Atsumi R; Ono C; Tanaka N; Terasawa H; Soga T
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3209-15. PubMed ID: 15149677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin.
    Rodrigues EG; Dobroff AS; Cavarsan CF; Paschoalin T; Nimrichter L; Mortara RA; Santos EL; Fázio MA; Miranda A; Daffre S; Travassos LR
    Neoplasia; 2008 Jan; 10(1):61-8. PubMed ID: 18231639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid tumor therapy by selectively targeting stromal endothelial cells.
    Liu S; Liu J; Ma Q; Cao L; Fattah RJ; Yu Z; Bugge TH; Finkel T; Leppla SH
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4079-87. PubMed ID: 27357689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukaemia xenotransplantation in zebrafish--chemotherapy response assay in vivo.
    Corkery DP; Dellaire G; Berman JN
    Br J Haematol; 2011 Jun; 153(6):786-9. PubMed ID: 21517816
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitumor effect of pluramycin A on experimental animal tumors; studies on antitumor products of Streptomyces. II.
    NISHIBORI A
    J Antibiot (Tokyo); 1957 Sep; 10(5):213-8. PubMed ID: 13513514
    [No Abstract]   [Full Text] [Related]  

  • 38. Does color of an antitumor agent predict for clinical antitumor activity?
    Von Hoff DD; Kuhn J; Clark G
    Cancer Chemother Pharmacol; 1981; 6(1):93-4. PubMed ID: 7273269
    [No Abstract]   [Full Text] [Related]  

  • 39. Diverse Synthesis of Fused Polyheterocyclic Compounds via [3 + 2] Cycloaddition of In Situ-Generated Heteroaromatic
    Wang ZH; Zhang T; Shen LW; Yang X; Zhang YP; You Y; Zhao JQ; Yuan WC
    Molecules; 2023 May; 28(11):. PubMed ID: 37298885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, Structural Characterization, and Cytotoxic Activity of New Benzo[d]imidazo[2,1-b]thiazole Derivatives Against MCF-7 Breast Cancer Cells.
    Ahmadi N; Shahhosseini S; H Shirazi F; Farnam G; Zarghi A
    Iran J Pharm Res; 2022 Dec; 21(1):e127041. PubMed ID: 36710987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.